Effects of clozapine on heart rate dynamics and their relationship with therapeutic response in treatment-resistant schizophrenia

Journal of Clinical Psychopharmacology

Volumn 33, Issue 1, 2013, Pages 69-73

  Kim, Jong Hoon ^a   Yi, Sang Hoon ^b   Lee, Jinyoung ^a   Kim, Yong Sik ^c,d  

^a Gachon University   (South Korea)

^b Inje University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Dongguk University Ilsan Hospital   (South Korea)

Author keywords

clozapine; heart rate variability; nonlinear complexity measures; treatment response

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE;

ADULT; AGITATED DEPRESSION; ANXIETY DISORDER; APPROXIMATE ENTROPY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; ENTROPY; FEMALE; HEART ELECTROPHYSIOLOGY; HEART RATE VARIABILITY; HUMAN; INSOMNIA; MALE; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SAMPLE ENTROPY; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NONLINEAR DYNAMICS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REPUBLIC OF KOREA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84873087717     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31827d14e3     Document Type: Article

References (38)

1. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
2. Lieberman JA, Safferman AZ, Pollack S, et al. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry. 1994;151:1744-1752.
3. Pickar D, Owen RR, Litman RE, et al. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Arch Gen Psychiatry. 1992;49:345-353.
4. Miller DD, Fleming F, Holman TL, et al. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study. J Clin Psychiatry. 1994;55(suppl B):117-121.
5. Knott V, Labelle A, Jones B, et al. EEG hemispheric asymmetry as a predictor and correlate of short-term response to clozapine treatment in schizophrenia. Clin Electroencephalogr. 2000;31:145-152.
6. Kim JH, Yi SH, Yoo CS, et al. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:371-378.
7. Mujica-Parodi LR, Yeragani V, Malaspina D. Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology. 2005;51:10-15.
8. Bär KJ, Boettger MK, Koschke M, et al. Non-linear complexity measures of heart rate variability in acute schizophrenia. Clin Neurophysiol. 2007;118:2009-2015.
9. Bär KJ, Boettger MK, Berger S, et al. Decreased baroreflex sensitivity in acute schizophrenia. J Appl Physiol. 2007;102:1051-1056.
10. Bär KJ, Koschke M, Berger S, et al. Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia. J Clin Psychopharmacol. 2008;28:694-698.
11. Peupelmann J, Boettger MK, Ruhland C, et al. Cardio-respiratory coupling indicates suppression of vagal activity in acute schizophrenia. Schizophr Res. 2009;112:153-157.
12. Seely AJ, Macklem PT. Complex systems and the technology of variability analysis. Crit Care. 2004;8:R367-R384.
13. Pincus SM. Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA. 1991;88:2297-2301.
14. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-I). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1996.
15. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
16. Kay SR, Opler LA. Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS). New York, NY: Albert Einstein College of Medicine; 1988.
17. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Bethesda, MD: US Department of Health, Education, and Welfare; 1976. Publication ADM 76-338 ed.
18. Lindenmayer JP, Czobor P, Volavka J, et al. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. J Clin Psychiatry. 2002;63:931-935.
19. Suzuki T, Remington G, Arenovich T, et al. Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia. Br J Psychiatry. 2011;199:275-280.
20. Haapaniemi TH, Pursiainen V, Korpelainen JT, et al. Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001;70:305-310.
21. Yeragani VK, Pohl R, Mallavarapu M, et al. Approximate entropy of symptoms of mood: an effective technique to quantify regularity of mood. Bipolar Disord. 2003;5:279-286.
22. Yeragani VK, Sobolewski E, Kay J, et al. Effect of age on long-term heart rate variability. Cardiovasc Res. 1997;35:35-42.
23. Yeragani VK, Sobolewski E, Jampala VC, et al. Fractal dimension and approximate entropy of heart period and heart rate: awake versus sleep differences and methodological issues. Clin Sci (Lond). 1998;95:295-301.
24. Richman JS, Moorman Jr. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol. 2000;278:H2039-H2049.
25. Lake DE, Richman JS, Griffin MP, et al. Sample entropy analysis of neonatal heart rate variability. Am J Physiol Regul Integr Comp Physiol. 2002;283:R789-R797.
26. Agelink MW, Malessa R, Baumann B, et al. Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res. 2001;11:99-108.
27. Zahn TP, Pickar D. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine. Biol Psychiatry. 1993;34:3-12.
28. Agelink MW, Malessa R, Kamcili E, et al. Cardiovascular autonomic reactivity in schizophrenics under neuroleptic treatment: a potential predictor of short-term outcome? Neuropsychobiology. 1998;38:19-24.
29. Zahn TP, Frith CD, Steinhauer SR. Autonomic functioning in schizophrenia: electrodermal activity, heart rate, pupillography. In: Steinhauer, S.R., Gruzelier, J.H., Zubin, J, eds. Handbook of Schizophrenia: Vol. 5. Neuropsychology, Psychophysiology and Information Processing. Amsterdam: Elsevier; 1991:185-224.
30. Williams LM, Das P, Harris AW, et al. Dysregulation of arousal and amygdalaVprefrontal systems in paranoid schizophrenia. Am J Psychiatry. 2004;161:480-489.
31. Breier A. Clozapine and noradrenergic function: support for a novel hypothesis for superior efficacy. J Clin Psychiatry. 1994;55 (suppl B):122-125.
32. Breier A, Buchanan RW, Waltrip RW 2nd, et al. The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Neuropsychopharmacology. 1994;10:1-7.
33. Agelink MW, Sayar K, Klieser E. Usefulness of heart rate variability (HRV) for monitoring clozapine plasma levels. Pharmacopsychiatry. 2003;36:166-167.
34. Kingwell BA, Thompson JM, Kaye DM, et al. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation. 1994;90:234-240.
35. Agelink MW, Majewski T, Wurthmann C, et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol. 2001;21:8-13.
36. Breier A, Buchanan RW, Irish D, et al. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hosp Community Psychiatry. 1993;44:1145-1149.
37. Skrapari I, Tentolouris N, Perrea D, et al. Baroreflex sensitivity in obesity: relationship with cardiac autonomic nervous system activity. Obesity (Silver Spring). 2007;15:1685-1693.
38. Gaebel W, Awad AG. Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Wien: Springer-Verlag; 1994.